metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Usefulness of extended inflammatory parameters related to neutrophil activation ...
Journal Information
Vol. 102. Issue 6.
Pages 300-306 (June 2024)
Visits
91
Vol. 102. Issue 6.
Pages 300-306 (June 2024)
Original article
Full text access
Usefulness of extended inflammatory parameters related to neutrophil activation reported by Sysmex XN-1000 hematology analyzer for predicting complicated acute appendicitis. Comparison with canonical inflammatory laboratory tests
Utilidad del perfil inflamatorio extendido relacionado con la activación de los neutrofilos informado por el analizador hematológico Sysmex XN-1000 para la predicción de apendicitis aguda complicada. Comparación con biomarcadores de inflamación tradicionales
Visits
91
María Isabel Díaz Lópeza,1, Elena Crespo Álvarezb, Álvaro Martínez Manzanob, Eloísa Urrechagac,d, Manuel Tomás Orgaz Moralesa, Mercedes González Moralesa, Elena Martín Garcíaa, Luis García de Guadiana-Romualdoa,1,
Corresponding author
lgr28w@ad.sms.carm.es

Corresponding author.
a Laboratory Medicine Department, Hospital Universitario Santa Lucía, Cartagena, Spain
b General Surgery Department, Hospital Universitario Santa Lucía, Cartagena, Spain
c Biocruces Bizkaia Health Research Institute, Baracaldo, Spain
d Laboratory Medicine Department, Hospital Galdakao-Usansolo, Galdakao, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (2)
Table 1. Laboratory findings in both groups (non-complicated vs complicated acute appendicitis).
Tables
Table 2. ROC curves for complicated acute appendicitis.
Tables
Show moreShow less
Abstract
Aim

Accurate diagnosis of complicated appendicitis is of importance to ensure that patients receive early and effective treatment, minimizing the risk of postoperative complications to promote successful recovery. Biochemical markers are a promising tool to identify complicated appendicitis. We aimed to evaluate the potential role of novel parameters related with neutrophil activation, known as “Extended Inflammation Parameters” (EIP), included in blood cell count reported by Sysmex XN-Series analyzers, compared to other canonical biomarkers in identifying complicated appendicitis.

Method

Prospective observational study including patients with confirmed diagnosis of acute appendicitis. C-reactive protein (CRP), procalcitonin, cell blood count, including white blood cell (WBC), absolute neutrophil (ANC) and immature granulocyte (IG) count and EIP (neutrophil reactivity [NEUT-RI] and granularity intensity [NEUT-GI]) were analyzed before surgery. Their accuracy to diagnose complicated appendicitis was tested in an ROC curve analysis.

Results

Our population study included 119 patients, and appendicitis was complicated in 58 (48.7%). NLR, CRP and procalcitonin levels, ANC and IG count and NEUT-RI and NEUT-GI were higher in patients with complicated appendicitis. Regarding accuracy for complicated appendicitis, CRP was the biomarker with the highest performance (ROC AUC: 0.829), with an optimal cutoff of 73.1 mg/L (sensitivity: 63.8%, specificity: 88.5%). NEUT-RI and NEUT-GI achieved both significant but poor accuracy, with ROC AUC of 0.606 and 0.637, respectively.

Conclusions

Novel laboratory tests reported by Sysmex XN-Series analyzers have poor accuracy for identifying complicated appendicitis. In this study, CRP was the biomarker with the highest performance and may be useful as predictor of the severity of acute appendicitis.

Keywords:
Complicated acute appendicitis
Extended inflammation parameters
C-reactive protein
Biomarkers
Sysmex XN
Resumen
Objetivo

El diagnóstico de la apendicitis complicada es esencial para garantizar el tratamiento precoz y eficaz del paciente, minimizando el riesgo de complicaciones postquirúrgicas. Los biomarcadores son una herramienta prometedora para la identificación de esta condición. En este estudio evaluamos los nuevos parámetros (“Perfil Inflamatorio Extendido” [PIE]) incluidos en el hemograma de los analizadores Sysmex de la Serie XN, en comparación con marcadores tradicionales, para identificar la apendicitis complicada.

Método

Estudio prospectivo observacional incluyendo pacientes con diagnóstico confirmado de apendicitis aguda. Previo a la cirugía se midieron proteína C reactiva (PCR), procalcitonina, recuento celular en sangre (recuento de leucocitos, recuento absoluto de neutrófilos [RAN] y granulocitos inmaduros [GI]) y PIE (intensidad de la reactividad (NEUT-RI) y de la granularidad (NEUT-GI) de neutrófilos). Su rendimiento se analizó mediante análisis de curvas ROC.

Resultados

La población incluyó 119 pacientes y la apendicitis fue clasificada como complicada en 58 (48,7%). El cociente neutrófilos/linfocitos, las concentraciones de PCR y procalcitonina, el RAN y de GI y NEUT-RI y NEUT-GI fueron más altos en pacientes con apendicitis complicada. La PCR fue el biomarcador con mayor rendimiento (AUC ROC: 0.829), con un punto de corte óptimo de 73,1 mg/L (sensibilidad: 63,8%, especificidad: 88,5%). El rendimiento de NEUT-RI y NEUT-GI fue pobre, con AUC ROC de 0,606 y 0,637, respectivamente.

Conclusiones

Los nuevas medidas de laboratorio de los analizadores Sysmex de la Serie XN tienen un pobre rendimiento para identificar la apendicitis complicada. En este estudio, la PCR fue el biomarcador con el mayor rendimiento y puede ser útil como predictor de la gravedad de la apendicitis aguda.

Palabras claves:
Apendicitis aguda complicada
Parámetros de inflamación extendidos
Proteína C reactiva
Biomarcadores
Sysmex XN
Graphical abstract
Full Text
Introduction

Acute appendicitis is one of the most common general surgical emergencies worldwide.1 Patients with suspected acute appendicitis are evaluated with several diagnostic tools, such as clinical examination, scoring systems, biochemical testing and imaging modalities. Although appendectomy has long been considered the standard of care for acute appendicitis, conservative management with antibiotics has been reported as a safe strategy for non-complicated appendicitis.2,3 Therefore, the differential diagnosis between both conditions is a challenge for clinicians, and there is a need for novel early predictors of the severity of acute appendicitis that would enable us to provide optimal treatment for each patient. Biochemical markers are a promising, reliable diagnostic tool to identify negative cases as well as complicated acute appendicitis.4

Because acute appendicitis is a local inflammatory process in the early stage, inflammatory-related biomarkers, such as white blood cell (WBC) and absolute neutrophil counts (ANC), C-reactive protein (CRP), procalcitonin, interleukin-6, fibrinogen, immature granulocyte (IG) count or neutrophil-lymphocyte ratio (NLR) have been evaluated as predictors of complicated acute appendicitis, with controversial results.5–11

Advances in blood count technology bring novel parameters and provide deeper insights into the blood cells than cell count alone. Sysmex XN-Series analyzers offer additional parameters, known as “Extended Inflammation Parameters” (EIP), which make it possible to quantitatively assess IG and the activation status of neutrophils during inflammation. These analyzers use flow cytometry fluorescence technology to obtain data about cell membrane composition and cytoplasmic activity. Hence, parameters related to neutrophils, such as neutrophil reactivity (NEUT-RI) and granularity intensity (NEUT-GI), are indicative of the activation status of the neutrophilic granulocytes, and their measurement takes into account the metabolic activity of neutrophils, the internal structure, and cell size.12

In a previous study, we reported that, among EIP obtained through CBC analysis by the Sysmex-XN 1000 hematology analyzer, parameters associated with neutrophil activation are not useful for the early diagnosis of acute appendicitis.13 However, their value for predicting complicated acute appendicitis has not yet been evaluated. The inclusion of these novel laboratory tests as criteria for decision making in patients with acute appendicitis would be of interest because they are readily available from a routine complete blood count with differentials, at no additional cost.

In this study, we aimed to evaluate the potential role of these novel inflammatory parameters to identify complicated acute appendicitis, in comparison with CRP, WBC, ANC, IG count, NLR and procalcitonin, which could provide an assessment basis to decide between surgical or conservative treatment options.

MethodsStudy design and population study

This was a single-center, prospective, observational study conducted from May 2021 to November 2022 that included adult and pediatric patients admitted to the Emergency Department with clinical suspicion of acute appendicitis requiring surgical treatment according to the attending surgeon’s judgment, followed by pathology results confirming the diagnosis of acute appendicitis. Patients who were pregnant, received previous antibiotics and/or immunosuppressive or steroid treatment or under conservative management, presented hematologic malignancy, or had missing data were excluded from the study. Patients were recruited through convenience sampling when the investigators participating in the study were present.

To evaluate the value of biomarkers for complicated acute appendicitis, we divided the patients into 2 groups according to histopathological findings described in the specimen after surgery: (a) non-complicated group (phlegmonous or catarrhal); and (b) complicated group (perforated and/or gangrenous).

Blood sampling and laboratory methods

On admission to the Emergency Department, initial management included venous blood sampling for routine laboratory workup, including CRP, procalcitonin and blood cell count with WBC, ANC and IG count.

Regarding laboratory assays, serum CRP levels were measured by an immunoturbidimetric assay in Cobas c702 analyzer (Roche Diagnostics, Switzerland), serum procalcitonin levels by a chemiluminescent enzyme immunoassay on G600II analyzer (Fujirebio Diagnostics Inc, Japan) and WBC, ANC and IG count by fluorescence flow cytometry, on Sysmex XN-1000 analyzer (Sysmex, Kobe, Japan), according to manufacturer recommendations. NLR was also calculated. Furthermore, for analysis, IG count and EIP associated with neutrophil activation, (NEUT-RI and NEUT-GI), were collected. These latter laboratory tests were not reported to attending physicians.

This study was approved by the local Ethics Committee and performed under a waiver of informed consent. The work was carried out in accordance with the guidelines of the Declaration of Helsinki of the World Medical Association. All data used in the study was retrieved from results obtained during routine laboratory diagnostics, without the need for additional blood collection or storage for later measurements.

Statistical analysis

The normality of continuous variables was analyzed by the Kolmogorov–Smirnov or Shapiro–Wilk tests, and they are reported as median (interquartile range [IQR]) or mean (standard deviation), as appropriate. Categorical variables are presented as frequency and percentage in each category. Mann–Whitney U and chi-squared or Fisher exact tests were used, as appropriate, to compare continuous and categorical data between groups, respectively.

To assess the discrimination ability for complicated acute appendicitis of circulating biomarkers, we estimated receiver operating characteristic (ROC) curves and area under the curves (AUC).14 Interpretation of AUC is as follows: 1.0 is a perfect discriminative biomarker, 0.9−0.99 is an excellent biomarker, 0.8−0.89 is a good biomarker, 0.7−0.79 is a fair biomarker, 0.51−0.69 is a poor biomarker, and ≤0.5 is of no value.15 We additionally determined the optimal cutoff value using Youden’s index,16 and sensitivity, specificity, positive likelihood ratio (LR) and negative LR were calculated. The Delong method was used for comparison of significant AUC.17

We performed analyses using the software packages SPSS 21.0 (SPSS Inc., IL, USA) and MedCalc 15.0 (MedCalc Software, Ostend, Belgium). In all tests, a 2-sided P-value of <.05 was considered statistically significant.

Results

This study included a total of 119 patients (median age: 28 years, interquartile range [IQR]: 15–47 years, range: 6–101 years; 75 [63%] male) with a confirmed diagnosis of acute appendicitis who underwent appendectomy. According to the histopathological findings, 58 (48.7%) patients were classified in the complicated group and 61 (51.3%) in the non-complicated group. Patients with complicated acute appendicitis were significantly older (median age: 40 years, IQR: 20–57) vs the non-complicated group (median age: 18 years, IQR: 13–35; P = .004). No differences were detected according to gender (P = .353).

Laboratory findings are listed in Table 1. Higher NLR, CRP and procalcitonin levels, ANC and IG count and NEUT-RI and NEUT-GI were found in patients with complicated acute appendicitis, with no significant difference between groups for WBC count.

Table 1.

Laboratory findings in both groups (non-complicated vs complicated acute appendicitis).

Biomarker  Total population  Non-complicated  Complicated  P 
  n = 119  n = 61 (51.3%)  n = 58 (48.7%)   
CRP (mg/L)  37 (9.3−103.7)  21.1 (3.5−37.8)  103.3 (36.9−198.7)  <0.001 
Procalcitonin (ng/mL)  0.10 (0.04−0.32)  0.05 (0.03−0.16)  0.15 (0.06−0.74)  <0.001 
WBC count (×109/L)  13.82 (11.70−17.96)  13.55 (11.67−16.73)  14.96 (12.05−20.20)  0.104 
ANC (×109/L)  12.12 (4.80)  11.20 (4.33)  13.10 (5.6)  0.043 
IG count (×109/L)  0.05 (0.04−0.1)  0.05 (0.03−0.07)  0.08 (0.04−0.12)  0.004 
NEUT-RI (SI)  49.1 (47.1−51.1)  48.4 (47.1−50.2)  50.0 (47.1−51.5)  0.046 
NEUT-GI (SI)  153.9 (4.5)  152.9 (4.4)  154.9 (4.4)  0.015 
NLR  7.80 (5.24−12.31)  6.08 (4.11−10.4)  9.90 (6.9−14.1)  0.001 

Values expressed as median (IQR) or mean (SD), as appropriate.

Itilicized values is to highlight that the p-value is significant (< 0,05).

Abbreviations: CRP: C-reactive protein; WBC: white blood cell; ANC: absolute neutrophil count; IG: immature granulocytes; NEUT-RI: neutrophil reactivity; NEUT-GI: granularity intensity; NLR: neutrophil-to-lymphocyte ratio.

In the ROC analysis, a significant AUC was estimated for CRP and procalcitonin levels, NLR, ANC and IG count and NEUT-RI and NEUT-GI (Table 2 and Fig. 1). CRP was the biomarker with the highest accuracy for complicated acute appendicitis, with a significant difference compared to procalcitonin, NLR, ANC, IG count and both parameters related to neutrophil activation included in EIP. According to the Youden index, the optimal cutoff was 73.1 mg/L, achieving a sensitivity of 63.8% (95% CI: 50.1–76.0), specificity of 88.5% (95% CI: 77.8–95.3), positive LR of 5.6 (4.5–6.9) and negative LR of 0.4 (0.2−0.9). As criteria to rule out complicated acute appendicitis, a CRP cutoff of 7.7 mg/L (reference value in our laboratory: <5 mg/L) achieved a negative LR of 0.2.

Table 2.

ROC curves for complicated acute appendicitis.

Biomarker  ROC AUC (95%CI)  P  P for comparison vs CRP 
CRP  0.829 (0.756–0.902)  <0.001  – 
Procalcitonin  0.700 (0.606–0.794)  <0.001  0.003 
NLR  0.675 (0.578–0.771)  0.001  0.011 
IG count  0.653 (0.554–0.753)  0.004  0.006 
NEUT-GI  0.637 (0.536–0.737)  0.010  0.001 
NEUT-RI  0.606 (0.503–0.709)  0.046  <0.001 
ANC  0.599 (0.496–0.702)  0.062  1 
WBC count  0.586 (0.483–0.690)  0.104  1 

Itilicized values is to highlight that the p-value is significant (< 0,05).

Abbreviations: CI: confidence interval; CRP: C-reactive protein; WBC: white blood cell; ANC: absolute neutrophil count; IG: immature granulocytes; NEUT-RI: neutrophil reactivity; NEUT-GI: granularity intensity; NLR: neutrophil-to-lymphocyte ratio.

1

Only tests with a significant ROC AUC were compared vs CRP.

Fig. 1.

Receiver operating characteristic curves to identify complicated acute appendicitis.

(0.18MB).
Discussion

Acute appendicitis is the most frequent urgent abdominal surgery, and a delayed diagnosis may lead to disease complications, such as perforation and peritonitis, and more postoperative complications. Acute appendicitis occurs when the lumen of the vermiform appendix becomes inflamed, usually due to an obstruction. This obstruction can be caused by a fecalith (“fecal stone” or mass of feces), lymphoid hyperplasia (most commonly in children), a rare parasitic infection, or a tumor.18 Complicated appendicitis, which accounts for nearly 25% of cases requiring appendectomy, is the result of appendiceal rupture with subsequent abscess or phlegmon formation.18 Although complicated and non-complicated acute appendicitis share similar physical signs and symptoms, differences between both forms of acute appendicitis include mean time with symptoms (less than 24 h for uncomplicated appendicitis vs 48 h or more for complicated appendicitis) and other variables, such as age and gender.18 Because complicated and non-complicated acute appendicitis are associated with higher morbidity and mortality, it is a challenge for Emergency Department physicians and surgeons to reliably distinguish between them. Thus, there is a need to develop tools to potentially differentiate between these conditions in clinical practice to allow for stratified management in decisions.19

In recent decades, research has been carried out to identify circulating biomarkers in body fluids that could differentiate between non-complicated and complicated appendicitis. Biochemical markers have the potential to provide non-invasive objective criteria with no adverse effects for the patient. Conventional biomarkers like CRP, procalcitonin, WBC, ANC or NLR have been widely evaluated for diagnosis of acute appendicitis and to identify complicated disease. The role of emerging biomarkers related to ischemia or inflammation have also been evaluated for this purpose. For instance, ischemia-modified albumin has been reported as a novel and useful marker to distinguish gangrenous/perforated appendicitis from non-complicated appendicitis,20 although further prospectively designed and adequately powered studies are needed for this biomarker.21 Similarly, increased plasma calprotectin levels have been reported in patients with complicated acute appendicitis, improving the diagnostic accuracy of conventional biomarkers, such as CRP or WBC.22 Less known is the role of novel biomarkers like EIP that reflect neutrophil activation, functioning as a signature of the activation of immune system cells in the course of inflammation, which is a characteristic condition of acute appendicitis.1

The role of biomarkers for this purpose is controversial. Lietzén et al. concluded that laboratory markers like WBC and CRP are not reliable enough to accurately estimate the severity of acute appendicitis.23 Recently, a review including 65 laboratory tests concluded that no single biomarker can be used by clinicians to reliably differentiate between patients with complicated and non-complicated appendicitis.24 In our study, which evaluated canonical and novel parameters related with neutrophil activation reported by Sysmex analyzers, the main findings were: (1) although these novel tests showed statistically significant accuracy for complicated acute appendicitis, their discriminatory ability was poor15; and (2) CRP was the biomarker with the highest accuracy for complicated acute appendicitis (ROC AUC: 0.829), above other tested conventional inflammatory-related biomarkers, such as procalcitonin, IG count, NLR or ANC.

In a recent study by García-Amador et al.,5 CRP and neutrophil count, expressed as percentages, achieved ROC curves of 0.73 and 0.69, respectively; meanwhile, a predictive model combining both with other clinical and demographic variables showed an ROC AUC of 0.80, lower than CRP alone in our study, achieving an ROC AUC of 0.829. The optimal cutoff (73.1 mg/L) in our study was similar to the García-Amador et al. report (73.6 mg/L).5 In comparison with other studies, the ability of CRP to identify complicated appendicitis was very similar to the Güngör et al. article (ROC AUC: 0.82)25 but slightly lower than the Li et al. (ROC AUC: 0.902) study.7

In comparison with CRP, the value of procalcitonin for predicting complicated acute appendicitis has been less evaluated, and results are controversial. In the Li et al. study,7 this biomarker demonstrated very high accuracy, with an ROC AUC of 0.987, and its usefulness has been recently supported by meta-analyses reporting ROC AUC above 0.9.26,27 However, these results have not been confirmed in other recent studies; for example, Cakal et al. have reported the poor performance of procalcitonin (ROC AUC: 0.59) in differentiating complicated from non-complicated appendicitis.28 NLR has been also reported as a biomarker with a high performance for predicting complicated acute appendicitis.29 Finally, in acute complicated appendicitis, Turkes et al. reported an ROC AUC of 0.796 for IG count.10 In our study, the accuracies of procalcitonin (ROC AUC: 0.700), NLR (ROC AUC: 0.675) and IG count (ROC AUC: 0.653) were moderate and significantly lower than CRP.

Concerning novel inflammatory biomarkers reported by the Sysmex XN-Series analyzers, to our knowledge this is the first study testing their value for differentiating complicated and non-complicated appendicitis. Although significant differences were detected for NEUT-GI and NEUT-RI between both groups, the ability for diagnosis of complicated appendicitis was poor for both biomarkers (ROC AUC below 0.7, significantly lower than CRP), which would limit their use in clinical practice.

Our study presents certain limitations. First, it was a single-center observational study with a small sample size, and the results must be validated in a larger cohort. Second, no clinical scoring system (some including laboratory tests) was included for the comparison of tested biomarkers. However, recent studies do not support the routine use of established clinical scoring systems, such as the Alvarado score or Appendicitis Inflammatory Response (AIR) score, to distinguish between complicated vs non-complicated acute appendicitis.30 Furthermore, the use of these scores in real-life is scarce.31 A third limitation was that all patients included in this study had undergone appendectomy, and we did not analyze patients receiving conservative treatment.

In conclusion, our study suggests that novel laboratory parameters (EIP) reported by Sysmex XN-Series analyzers have poor accuracy for identifying complicated acute appendicitis. However, according to its discriminatory ability through ROC AUC, CRP is a good biomarker and may be useful as a predictor of the severity of acute appendicitis, and its inclusion in multivariate scoring systems would be beneficial to improve diagnostic performance and to provide a tool which is applicable in routine clinical practice.

Author contributions

MIDL and LGGR conceived and designed the study. MIDL, MGM and EMG collected laboratory test results. ECA and AMM contributed to the enrollment and classification of patients and clinical data collection. MTOM provided statistical advice to analyze the data. LGGR drafted the article, and EU contributed substantially to its revision. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Disclosure statement

The authors report there are no competing interests to declare.

References
[1]
A. Bhangu, K. Søreide, S. Di Saverio, J.H. Assarsson, F.T. Drake.
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management.
Lancet, 386 (2015), pp. 1278-1287
[2]
S. Perez Otero, J.W. Metzger, B.H. Choi, A. Ramaraj, J. Tashiro, K.A. Kuenzler, et al.
It’s time to deconstruct treatment-failure: a randomized controlled trial of nonoperative management of uncomplicated pediatric appendicitis with antibiotics alone.
J Pediatr Surg, 57 (2022), pp. 56-62
[3]
M. Podda, C. Gerardi, N. Cillara, N. Fearnhead, C.A. Gomes, A. Birindelli, et al.
Antibiotic treatment and appendectomy for uncomplicated acute appendicitis in adults and children: a systematic review and meta-analysis.
Ann Surg, 270 (2019), pp. 1028-1040
[4]
S. Di Saverio, M. Podda, B. De Simone, M. Ceresoli, G. Augustin, A. Gori, et al.
Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines.
World J Emerg Surg, 15 (2020), pp. 27
[5]
C. García-Amador, V. Arteaga Peralta, R. de la Plaza Llamas, M. Torralba, A. Medina Velasco, et al.
Evaluation of preoperative clinical and serological determinations in complicated acute appendicitis: a score for predicting complicated appendicitis.
Cir Esp (Engl Ed), 99 (2021), pp. 282-288
[6]
H.M. Moon, B.S. Park, D.J. Moon.
Diagnostic value of C-reactive protein in complicated appendicitis.
J Korean Soc Coloproctol, 27 (2011), pp. 122-126
[7]
Y. Li, Z. Zhang, I. Cheang, X. Li.
Procalcitonin as an excellent differential marker between uncomplicated and complicated acute appendicitis in adult patients.
Eur J Trauma Emerg Surg, 46 (2020), pp. 853-858
[8]
V.R. Rajalingam, A. Mustafa, A. Ayeni, F. Mahmood, S. Shammout, S. Singhal, et al.
The role of neutrophil-lymphocyte-ratio (NLR) and platelet-lymphocyte-ratio (PLR) as a biomarker for distinguishing between complicated and uncomplicated appendicitis.
Cureus, 14 (2022),
[9]
J. Arredondo Montero, G. Antona, A. Rivero Marcotegui, C. Bardají Pascual, M. Bronte Anaut, R. Ros Briones, et al.
Discriminatory capacity of serum interleukin-6 between complicated and uncomplicated acute appendicitis in children: a prospective validation study.
World J Pediatr, 18 (2022), pp. 810-817
[10]
G.F. Turkes, A. Unsal, H. Bulus.
Predictive value of immature granulocyte in the diagnosis of acute complicated appendicitis.
PLoS One, 17 (2022),
[11]
F.A. Alvarez-Alvarez, V.M. Maciel-Gutierrez, A.D. Rocha-Muñoz, J.H. Lujan, C.F. Ploneda-Valencia.
Diagnostic value of serum fibrinogen as a predictive factor for complicated appendicitis (perforated). A cross-sectional study.
Int J Surg, 25 (2016), pp. 109-113
[12]
A. Kowalska-Kepczynska, W. Kasprzycka, H. Donica.
Innovative assessment practices of inflammation.
Eur J Med Technol, 1 (2020), pp. 1-10
[13]
L. García de Guadiana-Romualdo, M.I. Díaz López, E. Crespo Álvarez, Á Martínez Manzano, E. Urrechaga, M.T. Orgaz Morales.
Usefulness of the extended inflammatory parameters related to neutrophil activation reported on Sysmex XN-1000 haematology analyser as indicators of acute appendicitis: comparison with canonical inflammatory laboratory tests.
Scand J Clin Lab Invest, 82 (2022), pp. 492-494
[14]
J. Arredondo Montero, N. Martín-Calvo.
Diagnostic performance studies: interpretation of ROC analysis and cut-offs.
Cir Esp (Engl Ed), (2022),
[15]
J.V. Carter, J. Pan, S.N. Rai, S. Galandiuk.
ROC-ing along: evaluation and interpretation of receiver operating characteristic curves.
Surgery, 159 (2016), pp. 1638-1645
[16]
W.J. Youden.
Index for rating diagnostic tests.
[17]
E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson.
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
Biometrics, 44 (1988), pp. 837-845
[18]
K.S. Perez, S.R. Allen.
Complicated appendicitis and considerations for interval appendectomy.
[19]
B. Skjold-Ødegaard, K. Søreide.
The diagnostic differentiation challenge in acute appendicitis: how to distinguish between uncomplicated and complicated appendicitis in adults.
Diagnostics (Basel), 12 (2022), pp. 1724
[20]
M.Ö Kılıç, C.E. Güldoğan, İ Balamir, M. Tez.
Ischemia-modified albumin as a predictor of the severity of acute appendicitis.
Am J Emerg Med, 35 (2017), pp. 92-95
[21]
A. Singh, Z. Pogorelić, A. Agrawal, C.M.L. Muñoz, D. Kainth, A. Verma, et al.
Utility of ischemia-modified albumin as a biomarker for acute appendicitis: a systematic review and meta-analysis.
J Clin Med, 12 (2023), pp. 5486
[22]
M. Cikot, K.D. Peker, M.A. Bozkurt, A. Kocatas, O. Kones, S. Binboga, et al.
Plasma calprotectin level: usage in distinction of uncomplicated from complicated acute appendicitis.
World J Emerg Surg, 11 (2016), pp. 7
[23]
E. Lietzén, J. Mällinen, J.M. Grönroos, T. Rautio, H. Paajanen, P. Nordström, et al.
Is preoperative distinction between complicated and uncomplicated acute appendicitis feasible without imaging?.
Surgery, 160 (2016), pp. 789-795
[24]
B. Sikander, J. Rosenberg, S. Fonnes.
Individual biomarkers in the blood are not yet applicable in diagnosing complicated appendicitis: a scoping review.
Am J Emerg Med, 67 (2023), pp. 100-107
[25]
A. Güngör, A. Göktuğ, M.M. Güneylioğlu, R.M. Yaradılmış, I. Bodur, B. Öztürk, et al.
Utility of biomarkers in predicting complicated appendicitis: can immature granulocyte percentage and C-reactive protein be used?.
Postgrad Med, 133 (2021), pp. 817-821
[26]
W. Cui, H. Liu, H. Ni, X. Qin, L. Zhu.
Diagnostic accuracy of procalcitonin for overall and complicated acute appendicitis in children: a meta-analysis.
Ital J Pediatr, 45 (2019), pp. 78
[27]
L. Dale.
The use of procalcitonin in the diagnosis of acute appendicitis: a systematic review.
Cureus, 14 (2022),
[28]
N. Cakal, M. Yucel, M.T. Demir, M. Yadigaroglu, M.H. Taskin, E. Ozgen, et al.
The value of serum I-FABP Level in the diagnosis of acute appendicitis.
Clin Lab., 68 (2022),
[29]
S. Hajibandeh, S. Hajibandeh, N. Hobbs, M. Mansour.
Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis.
Am J Surg, 219 (2020), pp. 154-163
[30]
F. Haak, O. Kollmar, A. Ioannidis, J.E. Slotta, M.B. Ghadimi, T. Glass, et al.
Predicting complicated appendicitis based on clinical findings: the role of Alvarado and Appendicitis Inflammatory Response scores.
Langenbecks Arch Surg, 407 (2022), pp. 2051-2057
[31]
A. Bhangu, RIFT Study Group on behalf of the West Midlands Research Collaborative.
Evaluation of appendicitis risk prediction models in adults with suspected appendicitis.
Br J Surg, 107 (2020), pp. 73-86

These authors contributed equally to this study.

Copyright © 2024. AEC
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.ciresp.2022.10.011
No mostrar más